Quarterly Result14 Aug 2026, 07:52 pm
Gufic Biosciences Declares Unaudited Q1 FY27 Results
AI Summary
Gufic Biosciences Ltd announced its unaudited financial results for the quarter ended June 30, 2026, on August 14, 2026. The Board of Directors also approved the incorporation of a subsidiary in the Philippines. The results were presented on both standalone and consolidated bases, with a limited review report attached. The company's primary business segment remains Pharmaceuticals.
Key Highlights
- Unaudited financial results for Q1 FY27 declared.
- Results available on standalone and consolidated basis.
- Board approved incorporation of a subsidiary in the Philippines.
- Limited review report on financial results is attached.
- Company operates within a single segment: Pharmaceuticals.
Price Impact
More from GUFICBIO
More in Quarterly Result